Image 1 of 1
GI MAP (Gastrointestinal Microbial Assay Plus) with Bile Acid Analysis
The Gastrointestinal Microbial Assay Plus (GI-MAP) can assess a patient’s microbiome from a single stool sample, with particular attention to microbes that may be disturbing normal microbial balance and may contribute to perturbations in the gastrointestinal (GI) flora or illness. The panel is a comprehensive collection of microbial targets as well as immune and digestive markers, including Zonulin to check for intestinal permeability or “Leaky Gut”. It screens for pathogenic bacteria, commensal bacteria, opportunistic pathogens, fungi, viruses, and parasites. It utilizes the latest automated quantitative PCR technology for microbial DNA analysis to give integrative and functional medicine practitioners a better view into the gastrointestinal microbiome. The Stool OMX add on gives insight bile acid metabolism and its impact on fat digestion, microbiome health, and gut motility.
Assess SCFA production, which reflects dietary microbial fermentation, inflammatory balance, and gut lining integrity.
Gain actionable insights to design personalized treatment plans targeting gut optimization.
The Gastrointestinal Microbial Assay Plus (GI-MAP) can assess a patient’s microbiome from a single stool sample, with particular attention to microbes that may be disturbing normal microbial balance and may contribute to perturbations in the gastrointestinal (GI) flora or illness. The panel is a comprehensive collection of microbial targets as well as immune and digestive markers, including Zonulin to check for intestinal permeability or “Leaky Gut”. It screens for pathogenic bacteria, commensal bacteria, opportunistic pathogens, fungi, viruses, and parasites. It utilizes the latest automated quantitative PCR technology for microbial DNA analysis to give integrative and functional medicine practitioners a better view into the gastrointestinal microbiome. The Stool OMX add on gives insight bile acid metabolism and its impact on fat digestion, microbiome health, and gut motility.
Assess SCFA production, which reflects dietary microbial fermentation, inflammatory balance, and gut lining integrity.
Gain actionable insights to design personalized treatment plans targeting gut optimization.